Jefferies, Piper Jaffray are bookrunners; Roth Capital, Stifel assist
By Devika Patel
Knoxville, Tenn., Aug. 2 - Marrone Bio Innovations, Inc. priced its $57 million initial public offering of stock with an $8.55 million greenshoe, according to a prospectus filed Friday with the Securities and Exchange Commission. The deal was announced July 1.
The company will sell 4.75 million common shares at $12.00 apiece.
Jefferies and Piper Jaffray are the joint bookrunning managers.
Settlement is expected Aug. 7.
Proceeds will be used to expand capacity at the company's manufacturing facility, for other capital expenditures, including purchasing equipment to facilitate our research and development efforts, working capital and other general corporate purposes.
Based in Davis, Calif., Marrone makes bio-based pest management and plant health products. It expects its shares to trade on the Nasdaq under the symbol "MBII."
| Issuer: | Marrone Bio Innovations, Inc.
|
| Issue: | Common stock
|
| Amount: | $57 million
|
| Greenshoe: | $8.55 million
|
| Shares: | 4.75 million
|
| Price: | $12.00
|
| Warrants: | No
|
| Bookrunners: | Jefferies and Piper Jaffray
|
| Co-managers: | Stifel and Roth Capital Partners
|
| Announcement date: | July 1
|
| Pricing date: | Aug. 2
|
| Settlement date: | Aug. 7
|
| Stock exchange: | Nasdaq: MBII
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
